In a research note published today, Canaccord analyst Mark Massaro reiterated a Buy rating on TearLab Corp. (NASDAQ:TEAR) with an $8 price target …
In a research note published Monday, Canaccord analyst Mark Massaro reiterated a Buy rating on Nanosphere (NASDAQ:NSPH) with a $3 price target, in …
In a research note released yesterday, Canaccord analyst Mark Massaro reiterated a Buy rating on OraSure Technologies (NASDAQ:OSUR) shares, and a $11 price target following investor meetings. Massaro commented: …
In a research note released today, Canaccord analyst Mark Massaro reiterated a Buy rating on Exact Sciences (NASDAQ: EXAS) and raised his price …
In a research note published today, Canaccord analyst Mark Massaro reiterated coverage with a “Buy” rating on OraSure Technologies (OSUR) and a price target of $11.00 as OSUR now expects to be …
In a research report released today, Canaccord analyst Mark Massaro reiterated coverage with a “Buy” rating on Nanosphere, Inc. (NSPH) and a price target of $5.
Canaccord Genuity analyst Mark Massaro yesterday upgraded shares of Idexx Laboratories (IDXX) from Hold to Buy and raised his target price to $148 (from $116) following the release of …
Canaccord analyst Mark Massaro maintains his Buy rating and $45 price target on Alere (ALR) following the news that Alere has decided not to pursue an IPO …
In a research note issued today, Canaccord analyst Mark Massaro reiterated a Buy rating and boosted his price target on OraSure Technologies (OSUR) to $11.00 …
